Back to search

United Kingdom· GB-APID-4745311000001105

Proleukin 18million unit powder for solution for injection vials

A aldesleukin product containing aldesleukin, registered in United Kingdom by Iovance Biotherapeutics UK SP Ltd. The same ATC class is registered in 10 of our 19 countries.

ATC L03AC01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedProleukin 18million unit powder for s…ATCL03AC01REGISTER NO.GB-APID-4745311000001…PACKS LISTED9CHECKEDOctober 2, 2026

Where it is registered

Aldesleukin is registered in 10 of 19 countries.

Countries holding a registration under ATC L03AC01 (aldesleukin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 6 of them publish a price we can compare per daily dose

Aldesleukin · ATC L03AC01

10 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Aldesleukin
Manufacturer
Iovance Biotherapeutics UK SP Ltd
Country
United Kingdom (GB)
ATC code
L03AC01
ATC class
Aldesleukin
Defined daily dose
0.2 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
October 2, 2026

Packs & prices · 9

  • gtin
    8714023000412
  • gtin
    5010678916072
  • gtin
    7613421021269
  • gtin
    05060229220271
  • gtin
    8714023000405
  • gtin
    5010678916065
  • gtin
    7613421021252
  • gtin
    05060229220264
  • gtin
    3737760000250

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

472 interactions on record for aldesleukin.

Graded by severity as the source publishes them — 46 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Aldesleukin · interactions on record

472 records

  • 46 severe
  • 411 moderate
  • 15 minor

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • CidofovirJ05AB12severe
  • DacarbazineL01AX04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aldesleukin in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aldesleukin products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Austria · Proleukin
  • Germany · Proleukin S
  • Spain · Proleukin
  • France · Proleukin
  • Italy · Proleukin
  • Netherlands · Proleukin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/65fecd3f-ba83-4d02-9f19-c0c61fb02ae2
GET /v1/drugs/65fecd3f-ba83-4d02-9f19-c0c61fb02ae2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4745311000001105",
  "desc": "Proleukin 18million unit powder for solution for injection vials (Iovance Biotherapeutics UK SP Ltd)",
  "form": "Powder for solution for injection",
  "vpid": "39694111000001109",
  "source": "dmd",
  "vtm_id": "774454002",
  "strength": "18 mega unit",
  "substance": "Aldesleukin",
  "ingredient": "Aldesleukin",
  "supplier_code": "45559811000001107"
}

See everything about aldesleukin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.